IBX 12.5% 7.0¢ imagion biosystems limited

Ann: Imagion Biosystems April 2022 Investor Newsletter, page-2

  1. 47 Posts.
    lightbulb Created with Sketch. 289
    Hi all -

    We are pleased to share our Investor Newsletter released today to the ASX.

    The issue includes a message from our CFO Geoff Hollis, highlights from our previously announced MagSense® HER2 breast cancer study progress update, a couple of Imagioneer spotlights, recent press coverage and other upcoming company news.

    You can read the full newsletter using this link: https://imagionbiosystems.com/news/april-2022-investor-newsletter/
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.